Shanghai North Carolina passed the acceptance of industry-university-research innovation project
Release time:
2020-07-22
Shanghai North Carolina Passed Acceptance of Industry-University-Research Innovation Project
News Recently, the "Research on Innovation and Creation of Heterocyclic Series Molecular Targeted Drugs with Quinazoline as the Core" project declared by Shanghai North Carolina Pharmaceutical Technology Co., Ltd. successfully passed the acceptance of industry-university-research projects of enterprises in the region organized by Shanghai Songjiang District Economic Committee.
"Research on Innovation and Creation of Heterocyclic Series Molecular Targeted Drugs with Quinazoline as the Core" is jointly researched by Shanghai Beika and Xie Hexin Research Group of School of Pharmacy of East China University of Science and Technology, aiming at the research and development of process improvement, quality, cost control and impurities of ceritinib bulk drug and its intermediate products, overcoming the shortcomings of existing technologies, the formation of novel, green, with cost control and quality advantages of new processes, new products. The development of this project has accelerated the progress of scientific and technological innovation and technology transformation, which is conducive to solving technical problems, cultivating innovative talents, improving innovation efficiency, building R & D teams, and promoting the transformation of R & D results through joint research with the resources of universities and enterprises.
According to the Implementation Rules of "Several Opinions on Promoting Innovation and Entrepreneurship to Promote Songjiang Economic Transformation and Upgrading" and "Songjiang District Industrial Technology Innovation Management Measures", Songjiang District Economic Commission invited people from the National Traditional Chinese Medicine Pharmaceutical Engineering Technology Research Center, Shanghai Animal Husbandry and Veterinary Research Institute and other units 4 experts checked and accepted the project.
During the project period, Shanghai North Carolina not only completed various tasks such as the research and development of the project's technical scheme, the optimization and construction of the innovation environment, and the construction of the R & D team, but also carried out the upgrading and transformation of the R & D laboratory, pilot experiment platform, EIA filing and supporting environmental protection treatment facilities, and passed the accreditation of Shanghai High-tech Enterprise and Songjiang Enterprise Technology Center and the review of Shanghai Specialized New Enterprise, the certification of Shanghai academician expert workstation and the acceptance of Shanghai science and technology giant (cultivation) have laid a more solid foundation for the application of subsequent scientific research projects, and also provided valuable experience for Shanghai North Carolina to apply for other scientific research projects. Shanghai North Carolina has opened a new chapter in scientific research development. The person in charge of Shanghai North Carolina said that in the future, Shanghai North Carolina will take advantage of the variety, technology and quality advantages that focus on development, adhere to product research and development innovation, and further build a characteristic brand in the field of small molecule targeted drugs for precision medicine. (Fang Yuyu)
More information
The company won the Taurus Award
On December 29, 2022, the "2022 High-quality Development Forum of listed companies and the 24th Golden Bull Award presentation ceremony of listed companies" jointly sponsored by China Securities News, Haikou Municipal Government and Haikou National High-tech Zone was held in Haikou. The list of Golden Bull Awards of listed companies was officially announced. With its outstanding performance, Jianfeng Group won the "2021 Golden Bull Most Investment Value Award".
2023
01-12
From December 11th to 12th, the 13th National Congress of the All-China Federation of Industry and Commerce was held in Beijing. Jiang Xiaomeng, chairman of the group company, attended the conference as a representative of Zhejiang.
2022
12-22
Yunnan Jianfeng won the title of "Harmonious Labor Relations Enterprise" in Yunnan Province
On November 18, the Yunnan Provincial Federation of Trade Unions, the Department of Human Resources and Social Security, the Entrepreneur Association and other units jointly issued a document to commend the harmonious labor relations enterprises in Yunnan Province from 2020 to 2021. Yunnan Jianfeng Cement Company is on the list and is the only enterprise in the urban area of Pu'er to receive this honor.
2022
12-13
Huang Ping Jianfeng won the title of "provincial green factory" in Guizhou
On November 30, the Guizhou Provincial Department of Industry and Information Technology released the 2022 list of green manufacturing units in Guizhou Province, and Huangping Jianfeng Cement Company was recognized as a "provincial green factory".
2022
12-13
On December 2, Yu Jianhong, general manager of the group company, gave a management lesson to the company's reserve management talents under the title of "Enterprise Management Innovation in Great Changes.
2022
12-13
On November 24, Jiang Xiaomeng, secretary of the party committee and chairman of the group company, gave a special party lesson to all party members and cadres of the company under the title of "comprehensively promoting the Great Rejuvenation of the Chinese Nation with Chinese Modernization" to interpret and preach the spirit of the 20th CPC National Congress.
2022
12-04
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page